// App-Quantinova.ai

10087 : Cardiovascular disease (CVD) risk factors and health behaviors after cisplatin-based chemotherapy (CHEM): A multi-institutional study of testicular cancer survivors (TCS) in the Platinum study.

Researchers

Presenter

  • Mohammad Issam Abu Zaid

Principal Investigators

  • Chunkit Fung

  • Anna Lynn Williams

  • Howard D. Sesso

  • Sarah L. Kerns

  • Shirin Ardeshir-Rouhani-Fard

  • Darren R. Feldman

  • Robert James Hamilton

  • David J. Vaughn

  • Clair Beard

  • Patrick Monahan

  • Sophie D. Fossa

  • Lawrence H. Einhorn

  • Lois B. Travis

Medical Centers

  • Indiana University School of Medicine, Indianapolis, IN

  • Wilmot Cancer Center, Rochester, NY

  • University of Rochester School of Medicine and Dentistry, Rochester, NY

  • Division of Preventive Medicine, Harvard Medical School, Boston, MA

  • University of Rochester Medcal Center, Rochester, NY

  • School of Public Health, Indiana University, Bloomington, IN

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

  • Dana-Farber Cancer Center/Brigham and Women's Hospital, Boston, MA

  • Oslo University Hospital, University of Oslo, Oslo, Norway

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN

  • Department of Medical Oncology, Indiana University, Indianapolis, IN

Locations

  • United States

  • Canada

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Testicular cancer

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved